Is Amazon an AI Stock?
With the market starting to look skittish on pure-play AI…
Sell
30
IRTC Quote, Financials, Valuation and Earnings
Last price:
$181.56
Seasonality move
:
19.06%
Day range:
$179.18 - $184.03
52-week range:
$81.10 - $212.00
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
8.20x
P/B ratio:
47.93x
Volume:
390.1K
Avg. volume:
507.8K
1-year change:
108.93%
Market cap:
$5.8B
Revenue:
$591.8M
EPS (TTM):
-$1.62
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
IRTC
iRhythm Technologies, Inc.
|
$184.7M | -$0.28 | 21.67% | -80.89% | $220.60 |
|
BAX
Baxter International, Inc.
|
$2.9B | $0.60 | 2.57% | 118.69% | $23.80 |
|
BSX
Boston Scientific Corp.
|
$5B | $0.71 | 15.72% | 105.56% | $126.48 |
|
IART
Integra LifeSciences Holdings Corp.
|
$414.3M | $0.43 | -2.2% | 217.77% | $15.50 |
|
QDEL
QuidelOrtho Corp.
|
$663.5M | $0.47 | -1.13% | 480.41% | $37.67 |
|
SYK
Stryker Corp.
|
$6B | $3.13 | 10.61% | 210.56% | $429.31 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
IRTC
iRhythm Technologies, Inc.
|
$181.35 | $220.60 | $5.8B | -- | $0.00 | 0% | 8.20x |
|
BAX
Baxter International, Inc.
|
$18.48 | $23.80 | $9.5B | 167.20x | $0.01 | 2.81% | 0.86x |
|
BSX
Boston Scientific Corp.
|
$97.72 | $126.48 | $144.9B | 52.27x | $0.00 | 0% | 7.54x |
|
IART
Integra LifeSciences Holdings Corp.
|
$13.57 | $15.50 | $1.1B | 70.14x | $0.00 | 0% | 0.63x |
|
QDEL
QuidelOrtho Corp.
|
$27.82 | $37.67 | $1.9B | -- | $0.00 | 0% | 0.69x |
|
SYK
Stryker Corp.
|
$364.35 | $429.31 | $139.3B | 47.84x | $0.84 | 0.92% | 5.77x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
IRTC
iRhythm Technologies, Inc.
|
85.74% | 2.140 | 13.23% | 4.47x |
|
BAX
Baxter International, Inc.
|
57.29% | 0.027 | 83.18% | 0.96x |
|
BSX
Boston Scientific Corp.
|
33.99% | 0.345 | 8.31% | 0.81x |
|
IART
Integra LifeSciences Holdings Corp.
|
65.91% | 0.130 | 179.84% | 1.47x |
|
QDEL
QuidelOrtho Corp.
|
58.27% | 1.095 | 142.21% | 0.82x |
|
SYK
Stryker Corp.
|
44.02% | 0.583 | 12.35% | 0.97x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
IRTC
iRhythm Technologies, Inc.
|
$137.1M | -$4M | -6.2% | -54.18% | -2.08% | $20.1M |
|
BAX
Baxter International, Inc.
|
$938M | $194M | -1.9% | -4.83% | 6.84% | $126M |
|
BSX
Boston Scientific Corp.
|
$3.3B | $1B | 8.19% | 12.46% | 20.55% | $1.2B |
|
IART
Integra LifeSciences Holdings Corp.
|
$226.1M | $25.9M | -14.85% | -37.15% | 6.43% | $25.8M |
|
QDEL
QuidelOrtho Corp.
|
$288.5M | $45.8M | -20.79% | -41.24% | 6.54% | -$94.7M |
|
SYK
Stryker Corp.
|
$3.7B | $1.4B | 7.89% | 14.06% | 22.52% | $1.4B |
iRhythm Technologies, Inc. vs. Competitors
-
Which has Higher Returns IRTC or BAX?
Baxter International, Inc. has a net margin of -2.7% compared to iRhythm Technologies, Inc.'s net margin of -1.8%. iRhythm Technologies, Inc.'s return on equity of -54.18% beat Baxter International, Inc.'s return on equity of -4.83%.
Company Gross Margin Earnings Per Share Invested Capital IRTCiRhythm Technologies, Inc.71.09% -$0.16 $854.9M BAXBaxter International, Inc.33.09% $0.02 $16.9B -
What do Analysts Say About IRTC or BAX?
iRhythm Technologies, Inc. has a consensus price target of $220.60, signalling upside risk potential of 21.64%. On the other hand Baxter International, Inc. has an analysts' consensus of $23.80 which suggests that it could grow by 28.79%. Given that Baxter International, Inc. has higher upside potential than iRhythm Technologies, Inc., analysts believe Baxter International, Inc. is more attractive than iRhythm Technologies, Inc..
Company Buy Ratings Hold Ratings Sell Ratings IRTCiRhythm Technologies, Inc.11 2 0 BAXBaxter International, Inc.2 13 1 -
Is IRTC or BAX More Risky?
iRhythm Technologies, Inc. has a beta of 1.099, which suggesting that the stock is 9.93% more volatile than S&P 500. In comparison Baxter International, Inc. has a beta of 0.612, suggesting its less volatile than the S&P 500 by 38.771%.
-
Which is a Better Dividend Stock IRTC or BAX?
iRhythm Technologies, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Baxter International, Inc. offers a yield of 2.81% to investors and pays a quarterly dividend of $0.01 per share. iRhythm Technologies, Inc. pays -- of its earnings as a dividend. Baxter International, Inc. pays out 180.98% of its earnings as a dividend.
-
Which has Better Financial Ratios IRTC or BAX?
iRhythm Technologies, Inc. quarterly revenues are $192.9M, which are smaller than Baxter International, Inc. quarterly revenues of $2.8B. iRhythm Technologies, Inc.'s net income of -$5.2M is higher than Baxter International, Inc.'s net income of -$51M. Notably, iRhythm Technologies, Inc.'s price-to-earnings ratio is -- while Baxter International, Inc.'s PE ratio is 167.20x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for iRhythm Technologies, Inc. is 8.20x versus 0.86x for Baxter International, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income IRTCiRhythm Technologies, Inc.8.20x -- $192.9M -$5.2M BAXBaxter International, Inc.0.86x 167.20x $2.8B -$51M
-
Which has Higher Returns IRTC or BSX?
Boston Scientific Corp. has a net margin of -2.7% compared to iRhythm Technologies, Inc.'s net margin of 14.91%. iRhythm Technologies, Inc.'s return on equity of -54.18% beat Boston Scientific Corp.'s return on equity of 12.46%.
Company Gross Margin Earnings Per Share Invested Capital IRTCiRhythm Technologies, Inc.71.09% -$0.16 $854.9M BSXBoston Scientific Corp.65.31% $0.50 $35.7B -
What do Analysts Say About IRTC or BSX?
iRhythm Technologies, Inc. has a consensus price target of $220.60, signalling upside risk potential of 21.64%. On the other hand Boston Scientific Corp. has an analysts' consensus of $126.48 which suggests that it could grow by 29.43%. Given that Boston Scientific Corp. has higher upside potential than iRhythm Technologies, Inc., analysts believe Boston Scientific Corp. is more attractive than iRhythm Technologies, Inc..
Company Buy Ratings Hold Ratings Sell Ratings IRTCiRhythm Technologies, Inc.11 2 0 BSXBoston Scientific Corp.25 2 0 -
Is IRTC or BSX More Risky?
iRhythm Technologies, Inc. has a beta of 1.099, which suggesting that the stock is 9.93% more volatile than S&P 500. In comparison Boston Scientific Corp. has a beta of 0.673, suggesting its less volatile than the S&P 500 by 32.691%.
-
Which is a Better Dividend Stock IRTC or BSX?
iRhythm Technologies, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Boston Scientific Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. iRhythm Technologies, Inc. pays -- of its earnings as a dividend. Boston Scientific Corp. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios IRTC or BSX?
iRhythm Technologies, Inc. quarterly revenues are $192.9M, which are smaller than Boston Scientific Corp. quarterly revenues of $5.1B. iRhythm Technologies, Inc.'s net income of -$5.2M is lower than Boston Scientific Corp.'s net income of $755M. Notably, iRhythm Technologies, Inc.'s price-to-earnings ratio is -- while Boston Scientific Corp.'s PE ratio is 52.27x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for iRhythm Technologies, Inc. is 8.20x versus 7.54x for Boston Scientific Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income IRTCiRhythm Technologies, Inc.8.20x -- $192.9M -$5.2M BSXBoston Scientific Corp.7.54x 52.27x $5.1B $755M
-
Which has Higher Returns IRTC or IART?
Integra LifeSciences Holdings Corp. has a net margin of -2.7% compared to iRhythm Technologies, Inc.'s net margin of -1.34%. iRhythm Technologies, Inc.'s return on equity of -54.18% beat Integra LifeSciences Holdings Corp.'s return on equity of -37.15%.
Company Gross Margin Earnings Per Share Invested Capital IRTCiRhythm Technologies, Inc.71.09% -$0.16 $854.9M IARTIntegra LifeSciences Holdings Corp.56.24% -$0.07 $3B -
What do Analysts Say About IRTC or IART?
iRhythm Technologies, Inc. has a consensus price target of $220.60, signalling upside risk potential of 21.64%. On the other hand Integra LifeSciences Holdings Corp. has an analysts' consensus of $15.50 which suggests that it could grow by 14.22%. Given that iRhythm Technologies, Inc. has higher upside potential than Integra LifeSciences Holdings Corp., analysts believe iRhythm Technologies, Inc. is more attractive than Integra LifeSciences Holdings Corp..
Company Buy Ratings Hold Ratings Sell Ratings IRTCiRhythm Technologies, Inc.11 2 0 IARTIntegra LifeSciences Holdings Corp.2 4 2 -
Is IRTC or IART More Risky?
iRhythm Technologies, Inc. has a beta of 1.099, which suggesting that the stock is 9.93% more volatile than S&P 500. In comparison Integra LifeSciences Holdings Corp. has a beta of 1.064, suggesting its more volatile than the S&P 500 by 6.408%.
-
Which is a Better Dividend Stock IRTC or IART?
iRhythm Technologies, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Integra LifeSciences Holdings Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. iRhythm Technologies, Inc. pays -- of its earnings as a dividend. Integra LifeSciences Holdings Corp. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios IRTC or IART?
iRhythm Technologies, Inc. quarterly revenues are $192.9M, which are smaller than Integra LifeSciences Holdings Corp. quarterly revenues of $402.1M. iRhythm Technologies, Inc.'s net income of -$5.2M is higher than Integra LifeSciences Holdings Corp.'s net income of -$5.4M. Notably, iRhythm Technologies, Inc.'s price-to-earnings ratio is -- while Integra LifeSciences Holdings Corp.'s PE ratio is 70.14x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for iRhythm Technologies, Inc. is 8.20x versus 0.63x for Integra LifeSciences Holdings Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income IRTCiRhythm Technologies, Inc.8.20x -- $192.9M -$5.2M IARTIntegra LifeSciences Holdings Corp.0.63x 70.14x $402.1M -$5.4M
-
Which has Higher Returns IRTC or QDEL?
QuidelOrtho Corp. has a net margin of -2.7% compared to iRhythm Technologies, Inc.'s net margin of -104.64%. iRhythm Technologies, Inc.'s return on equity of -54.18% beat QuidelOrtho Corp.'s return on equity of -41.24%.
Company Gross Margin Earnings Per Share Invested Capital IRTCiRhythm Technologies, Inc.71.09% -$0.16 $854.9M QDELQuidelOrtho Corp.41.19% -$10.78 $4.9B -
What do Analysts Say About IRTC or QDEL?
iRhythm Technologies, Inc. has a consensus price target of $220.60, signalling upside risk potential of 21.64%. On the other hand QuidelOrtho Corp. has an analysts' consensus of $37.67 which suggests that it could grow by 35.39%. Given that QuidelOrtho Corp. has higher upside potential than iRhythm Technologies, Inc., analysts believe QuidelOrtho Corp. is more attractive than iRhythm Technologies, Inc..
Company Buy Ratings Hold Ratings Sell Ratings IRTCiRhythm Technologies, Inc.11 2 0 QDELQuidelOrtho Corp.2 3 0 -
Is IRTC or QDEL More Risky?
iRhythm Technologies, Inc. has a beta of 1.099, which suggesting that the stock is 9.93% more volatile than S&P 500. In comparison QuidelOrtho Corp. has a beta of 0.584, suggesting its less volatile than the S&P 500 by 41.596%.
-
Which is a Better Dividend Stock IRTC or QDEL?
iRhythm Technologies, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. QuidelOrtho Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. iRhythm Technologies, Inc. pays -- of its earnings as a dividend. QuidelOrtho Corp. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios IRTC or QDEL?
iRhythm Technologies, Inc. quarterly revenues are $192.9M, which are smaller than QuidelOrtho Corp. quarterly revenues of $700.5M. iRhythm Technologies, Inc.'s net income of -$5.2M is higher than QuidelOrtho Corp.'s net income of -$733M. Notably, iRhythm Technologies, Inc.'s price-to-earnings ratio is -- while QuidelOrtho Corp.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for iRhythm Technologies, Inc. is 8.20x versus 0.69x for QuidelOrtho Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income IRTCiRhythm Technologies, Inc.8.20x -- $192.9M -$5.2M QDELQuidelOrtho Corp.0.69x -- $700.5M -$733M
-
Which has Higher Returns IRTC or SYK?
Stryker Corp. has a net margin of -2.7% compared to iRhythm Technologies, Inc.'s net margin of 14.18%. iRhythm Technologies, Inc.'s return on equity of -54.18% beat Stryker Corp.'s return on equity of 14.06%.
Company Gross Margin Earnings Per Share Invested Capital IRTCiRhythm Technologies, Inc.71.09% -$0.16 $854.9M SYKStryker Corp.61.86% $2.22 $38.9B -
What do Analysts Say About IRTC or SYK?
iRhythm Technologies, Inc. has a consensus price target of $220.60, signalling upside risk potential of 21.64%. On the other hand Stryker Corp. has an analysts' consensus of $429.31 which suggests that it could grow by 17.83%. Given that iRhythm Technologies, Inc. has higher upside potential than Stryker Corp., analysts believe iRhythm Technologies, Inc. is more attractive than Stryker Corp..
Company Buy Ratings Hold Ratings Sell Ratings IRTCiRhythm Technologies, Inc.11 2 0 SYKStryker Corp.13 9 0 -
Is IRTC or SYK More Risky?
iRhythm Technologies, Inc. has a beta of 1.099, which suggesting that the stock is 9.93% more volatile than S&P 500. In comparison Stryker Corp. has a beta of 0.890, suggesting its less volatile than the S&P 500 by 11.047%.
-
Which is a Better Dividend Stock IRTC or SYK?
iRhythm Technologies, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Stryker Corp. offers a yield of 0.92% to investors and pays a quarterly dividend of $0.84 per share. iRhythm Technologies, Inc. pays -- of its earnings as a dividend. Stryker Corp. pays out 41.74% of its earnings as a dividend. Stryker Corp.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios IRTC or SYK?
iRhythm Technologies, Inc. quarterly revenues are $192.9M, which are smaller than Stryker Corp. quarterly revenues of $6.1B. iRhythm Technologies, Inc.'s net income of -$5.2M is lower than Stryker Corp.'s net income of $859M. Notably, iRhythm Technologies, Inc.'s price-to-earnings ratio is -- while Stryker Corp.'s PE ratio is 47.84x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for iRhythm Technologies, Inc. is 8.20x versus 5.77x for Stryker Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income IRTCiRhythm Technologies, Inc.8.20x -- $192.9M -$5.2M SYKStryker Corp.5.77x 47.84x $6.1B $859M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Google Vs NVIDIA Stock: Which Is Best?
Alphabet (NASDAQ:GOOGL) and NVIDIA (NASDAQ:NVIDIA) are two of the market’s…
How High Could NVIDIA Stock Go?
NVIDIA (NASDAQ:NVDA) has been one of the best stocks to…
Stock Ideas
Buy
52
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 62x
Buy
61
Is AAPL Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 38x
Buy
63
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 40x
Alerts
Buy
54
SMX alert for Dec 5
SMX (Security Matters) Plc [SMX] is up 154.74% over the past day.
Sell
15
HOV alert for Dec 5
Hovnanian Enterprises, Inc. [HOV] is down 22.58% over the past day.
Buy
67
NUTX alert for Dec 5
Nutex Health, Inc. [NUTX] is up 18.9% over the past day.
